Elevated blood pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency

被引:116
作者
Lembo, G
Rockman, HA
Hunter, JJ
Steinmetz, H
Koch, WJ
Ma, L
Prinz, MP
Ross, J
Chien, KR
PowellBraxton, L
机构
[1] UNIV CALIF SAN DIEGO, DEPT MED, 0613C, AMER HEART ASSOC BUGHER FDN CTR MOL BIOL, LA JOLLA, CA 92093 USA
[2] UNIV CALIF SAN DIEGO, CTR MOL GENET, LA JOLLA, CA 92093 USA
[3] UNIV CALIF SAN DIEGO, DEPT PHARMACOL, LA JOLLA, CA 92093 USA
[4] DUKE UNIV, DEPT SURG, DURHAM, NC USA
[5] GENENTECH INC, S SAN FRANCISCO, CA 94080 USA
关键词
insulin-like growth factor I; mutagenesis; site-directed; myocardial contraction; hypertension; adrenergic receptors; beta receptors;
D O I
10.1172/JCI119086
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
To circumvent the embryonic lethality of a complete deficiency in insulin-like growth factor 1 (IGF-1), we generated mice homozygous for a site-specific insertional event that created a mutant IGF-1 allele (igf1(m)). These mice have IGF-1 levels 30% of wild type yet survive to adulthood, thereby allowing physiological analysis of the phenotype. Miniaturized catheterization technology revealed elevated conscious blood pressure in IGF-1(m/m) mice, and measurements of left ventricular contractility were increased. Adenylyl cyclase activity was enhanced in IGF-1(m/m) hearts, without an increase in beta-adrenergic receptor density, suggesting that crosstalk between IGF-1 and beta-adrenergic signaling pathways may mediate the increased contractility. The hypertrophic response of the left ventricular myocardium in response to aortic constriction, however, was preserved in IGF-1(m/m) mice. We conclude that chronic alterations in IGF-1 levels can selectively modulate blood pressure and left ventricular function, while not affecting adaptive myocardial hypertrophy in vivo.
引用
收藏
页码:2648 / 2655
页数:8
相关论文
共 46 条
[11]   VASCULAR REMODELING IN THE GROWTH-HORMONE TRANSGENIC MOUSE [J].
DILLEY, RJ ;
SCHWARTZ, SM .
CIRCULATION RESEARCH, 1989, 65 (05) :1233-1240
[12]   INDUCTION OF MYOCARDIAL INSULIN-LIKE GROWTH FACTOR-I GENE-EXPRESSION IN LEFT-VENTRICULAR HYPERTROPHY [J].
DONOHUE, TJ ;
DWORKIN, LD ;
LANGO, MN ;
FLIEGNER, K ;
LANGO, RP ;
BENSTEIN, JA ;
SLATER, WR ;
CATANESE, VM .
CIRCULATION, 1994, 89 (02) :799-809
[13]   INSULIN-LIKE GROWTH-FACTOR-I ENHANCES VENTRICULAR HYPERTROPHY AND FUNCTION DURING THE ONSET OF EXPERIMENTAL CARDIAC-FAILURE [J].
DUERR, RL ;
HUANG, S ;
MIRALIAKBAR, HR ;
CLARK, R ;
CHIEN, KR ;
ROSS, J .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (02) :619-627
[14]   IN-VITRO CHARACTERIZATION OF 4 NOVEL CLASSES OF GROWTH HORMONE-RELEASING PEPTIDE [J].
ELIAS, KA ;
INGLE, GS ;
BURNIER, JP ;
HAMMONDS, RG ;
MCDOWELL, RS ;
RAWSON, TE ;
SOMERS, TC ;
STANLEY, MS ;
CRONIN, MJ .
ENDOCRINOLOGY, 1995, 136 (12) :5694-5699
[15]   A preliminary study of growth hormone in the treatment of dilated cardiomyopathy [J].
Fazio, S ;
Sabatini, D ;
Capaldo, B ;
Vigorito, C ;
Giordano, A ;
Guida, R ;
Pardo, F ;
Biondi, B ;
Sacca, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (13) :809-814
[16]   INSULIN-MEDIATED VASODILATION - IMPAIRMENT WITH INCREASED BLOOD-PRESSURE AND BODY-MASS [J].
FELDMAN, RD ;
BIERBRIER, GS .
LANCET, 1993, 342 (8873) :707-709
[17]   INSULIN-LIKE GROWTH-FACTOR-I EXERTS GROWTH HORMONE-LIKE AND INSULIN-LIKE ACTIONS ON HUMAN MUSCLE PROTEIN-METABOLISM [J].
FRYBURG, DA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 267 (02) :E331-E336
[18]  
HADCOCK JR, 1992, J BIOL CHEM, V267, P26017
[19]   FAILURE OF CHRONIC ADMINISTRATION OF GROWTH-HORMONE TO AFFECT BLOOD-PRESSURE, VASCULAR REACTIVITY AND SODIUM-METABOLISM IN NORMAL RATS [J].
HARRAP, SB ;
MACPHERSON, F ;
WILSON, VG ;
DAVIES, DL ;
ISAKSSON, OPG ;
FOLKOW, B ;
LEVER, AF .
JOURNAL OF HYPERTENSION, 1988, 6 :S170-S172
[20]   TARGET FREQUENCY AND INTEGRATION PATTERN FOR INSERTION AND REPLACEMENT VECTORS IN EMBRYONIC STEM-CELLS [J].
HASTY, P ;
RIVERAPEREZ, J ;
CHANG, C ;
BRADLEY, A .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (09) :4509-4517